======= PCYT2 ======= == Gene Information == * **Official Symbol**: PCYT2 * **Official Name**: phosphate cytidylyltransferase 2, ethanolamine * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5833|5833]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99447|Q99447]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PCYT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PCYT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602679|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays an important role in the biosynthesis of the phospholipid phosphatidylethanolamine. Catalyzes the formation of CDP-ethanolamine. |CTP transf 2| |ethanolamine-phosphate cytidylyltransferase activity| |phosphatidylethanolamine biosynthetic process| |phosphatidylethanolamine metabolic process| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |cellular component| |organophosphate biosynthetic process| |lipid biosynthetic process| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |lipid metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-3| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-2.9| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.89| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.75| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.59| |[[:results:exp280|Daidzin 10μM R06 exp280]]|-2.3| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.21| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-2.19| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-2.06| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.02| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|-2| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|-1.97| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-1.89| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.88| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.81| |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|-1.8| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-1.79| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|-1.79| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-1.76| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.76| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|-1.74| |[[:results:exp298|Sucrose 20000μM R06 exp298]]|-1.72| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.71| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.76| |[[:results:exp518|RK-33 8μM R08 exp518]]|1.86| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|2.06| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|2.16| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.21| ^Gene^Correlation^ |[[:human genes:e:ept1|EPT1]]|0.527| |[[:human genes:p:pex7|PEX7]]|0.431| |[[:human genes:p:pex1|PEX1]]|0.412| |[[:human genes:a:arpc4|ARPC4]]|0.406| |[[:human genes:a:acsl4|ACSL4]]|0.404| |[[:human genes:e:etnk1|ETNK1]]|0.401| |[[:human genes:t:tmem189|TMEM189]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3919 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}